Drack Lab Celebrates Dr. Salma Hassan!

Drs. Salma Hassan and Arlene Drack.

The Drack Lab is excited to celebrate Dr. Salma Hassan, who successfully defended her dissertation, “Developing Novel Treatments for X-linked Retinoschisis (XLRS),” on August 25, 2025, through the Biomedical Science – Cell and Developmental Biology Graduate Program at the University of Iowa!

Throughout her doctoral research, Salma investigated novel therapeutic approaches for XLRS, an inherited retinal disorder characterized by fluid-filled cysts and impaired retinal function. Her gene therapy research revealed that while lower treatment doses could reduce retinal cysts, higher doses were needed to achieve functional improvements, highlighting the importance of assessing both retinal structure and function when evaluating treatment success.

Salma also investigated factors influencing retinal cyst formation, contributing to research on osmolarity-related mechanisms and uncovering the remarkable effect of light exposure on XLRS. Her findings demonstrated how lighting conditions can dramatically alter retinal cysts, underscoring the importance of standardizing light exposure and documenting examination conditions when assessing disease progression and treatment outcomes. These discoveries have also opened new avenues for investigating the mechanisms of cyst formation and exploring potential therapeutic approaches.

Beyond these discoveries, Salma contributed to the development of functional vision assessments in mouse models of retinal disease and played an important role in the lab's electrophysiology research. Building on her experience with electroretinography (ERG) and clinical testing during her PhD, she is now continuing as a postdoctoral researcher, further developing her expertise in patient electrophysiology. By bringing insights from clinical testing back to the laboratory, her work helps connect the challenges observed in patients with the questions and experimental approaches guiding preclinical research, informing how retinal diseases and emerging therapies are studied and evaluated.

Congratulations, Salma! We are grateful for your dedication, scientific curiosity, and contributions to the Drack Lab, and look forward to the impact of your work in this exciting next chapter!